Literature DB >> 18593274

CD7(-) T cells are late memory cells generated from CD7(+) T cells.

Gunter Rappl1, David Schrama, Andreas Hombach, Eva Katharina Meuer, Annette Schmidt, Jürgen C Becker, Hinrich Abken.   

Abstract

CD7(-) T cells constitute a distinct subset within the CD4(+) and CD8(+) T cell populations; their developmental and functional relationship to the majority of CD7(+) T cells, however, remained so far unresolved. We here elucidate that CD7(-) cells represent aging T cells in late memory cell development characterized by a high activation threshold, low effector capacities, and high sensitivity to activation-induced cell death (AICD). In this regard, CD7(-) T cells highly express killer cell lectin-like receptor G1 (KLRG-1), harbor telomeres of shorter lengths, a decreased telomerase expression per cell, and less amounts of T cell receptor rearrangement excision circles (TRECs) compared to CD7(+) cells. CD7(-) T cells are generated in vitro from naive CD7(+) T cells upon repetitive TCR/CD28 engagement, a process that is unidirectional and requires multiple cell divisions. Consequently, clonal expansions of CD7(-) T cells in vivo are less frequent than of CD7(+) T cells, the former can be traced back to those of CD7(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593274     DOI: 10.1089/rej.2007.0612

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  4 in total

1.  Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy.

Authors:  Erik Wambre; Jonathan H DeLong; Eddie A James; Rebecca E LaFond; David Robinson; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2011-10-05       Impact factor: 10.793

2.  Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

Authors:  S Oberbeck; A Schrader; K Warner; D Jungherz; G Crispatzu; J von Jan; M Chmielewski; A Ianevski; H H Diebner; P Mayer; A Kondo Ados; L Wahnschaffe; T Braun; T A Müller; P Wagle; A Bouska; T Neumann; S Pützer; L Varghese; N Pflug; M Thelen; J Makalowski; N Riet; H J M Göx; G Rappl; J Altmüller; M Kotrová; T Persigehl; G Hopfinger; M L Hansmann; H Schlößer; S Stilgenbauer; J Dürig; D Mougiakakos; M von Bergwelt-Baildon; I Roeder; S Hartmann; M Hallek; R Moriggl; M Brüggemann; T Aittokallio; J Iqbal; S Newrzela; H Abken; M Herling
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

3.  The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells.

Authors:  Gunter Rappl; Tobias Riet; Sabine Awerkiew; Annette Schmidt; Andreas A Hombach; Herbert Pfister; Hinrich Abken
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

4.  Increase of CD3+CD7- T cells in bone marrow predicts invasion in patients with T-cell non-Hodgkin's lymphoma.

Authors:  Ziyang Huang; Binbin Chen; Yixin Ling; Yangya Pan; Songfu Jiang; Shenghui Zhang; Kang Yu; Yixiang Han
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.